New hope for Tough-to-Treat myeloma: experimental combo enters phase 2
Disease control
Recruiting now
This study tests a new drug called cemsidomide combined with a steroid (dexamethasone) in about 100 adults whose multiple myeloma has come back or no longer responds to at least three prior treatments. The goal is to see if the combination shrinks tumors and how safe it is. Parti…
Phase: PHASE2 • Sponsor: C4 Therapeutics, Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC